Evoke Pharma (EVOK) Change in Receivables (2021 - 2025)
Historic Change in Receivables for Evoke Pharma (EVOK) over the last 5 years, with Q3 2025 value amounting to $285043.0.
- Evoke Pharma's Change in Receivables rose 136063.54% to $285043.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 4810.39%. This contributed to the annual value of $1.7 million for FY2024, which is 352217.71% up from last year.
- Evoke Pharma's Change in Receivables amounted to $285043.0 in Q3 2025, which was up 136063.54% from $393953.0 recorded in Q2 2025.
- In the past 5 years, Evoke Pharma's Change in Receivables ranged from a high of $778833.0 in Q1 2024 and a low of -$560833.0 during Q4 2023
- Its 5-year average for Change in Receivables is $166693.4, with a median of $104484.0 in 2021.
- In the last 5 years, Evoke Pharma's Change in Receivables plummeted by 101857.87% in 2023 and then skyrocketed by 136063.54% in 2025.
- Evoke Pharma's Change in Receivables (Quarter) stood at $73027.0 in 2021, then tumbled by 168.66% to -$50138.0 in 2022, then crashed by 1018.58% to -$560833.0 in 2023, then soared by 170.94% to $397855.0 in 2024, then fell by 28.36% to $285043.0 in 2025.
- Its Change in Receivables stands at $285043.0 for Q3 2025, versus $393953.0 for Q2 2025 and $91117.0 for Q1 2025.